http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104144940-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-64 |
| filingDate | 2012-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104144940-B |
| titleOfInvention | Cyclic peptide, preparation method from Ye Ye villages bacterium and the pharmaceutical composition for being used to prevent or treat mycobacterium relevant disease containing the cyclic peptide |
| abstract | The present invention relates to the novel anti-TB cyclic peptide from Ye Ye villages bacterium MJM5123, a kind of method for producing the antituberculosis peptide and the pharmaceutical composition for including the cyclic peptide for preventing and treating mycobacteria infections.The composition of the present invention includes MDR and XDR bacterial strains to duplication/not replicated Mycobacterium tuberculosis has very high activity, therefore it can effectively serve as therapeutic agent lungy. |
| priorityDate | 2011-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 168.